Publication in refereed journal
香港中文大学研究人员 ( 现职)
| 李咏恩教授 (药剂学院) |
全文
| 数位物件识别号 (DOI) http://dx.doi.org/10.1016/S0149-2918(02)85003-2 |
引用次数
Web of Sciencehttp://aims.cuhk.edu.hk/converis/portal/Publication/46WOS source URL
其它资讯
摘要Background: Over the past decade, use of the atypical antipsychotic drugs clozapine, risperidone, olanzapine, and quetiapine has significantly changed the treatment of schizophrenia in the United States. The ability to make optimal drug choices will depend on determining whether there are clinically important differences between these drugs.
着者Stimmel GL, Gutierrez MA, Lee V
期刊名称Clinical Therapeutics
出版年份2002
月份1
日期1
卷号24
期次1
出版社EXCERPTA MEDICA INC
页次21 - 37
国际标準期刊号0149-2918
语言英式英语
关键词atypical antipsychotic; QTc interval; weight gain; ziprasidone
Web of Science 学科类别Pharmacology & Pharmacy; PHARMACOLOGY & PHARMACY
